Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
55.5M
-
Number of holders
-
115
-
Total 13F shares, excl. options
-
28.9M
-
Shares change
-
-188K
-
Total reported value, excl. options
-
$547M
-
Value change
-
-$4.06M
-
Put/Call ratio
-
0.84
-
Number of buys
-
54
-
Number of sells
-
-58
-
Price
-
$18.92
Significant Holders of Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) as of Q3 2018
143 filings reported holding VYGR - Voyager Therapeutics, Inc. - Common Stock, $0.001 par value as of Q3 2018.
Voyager Therapeutics, Inc. - Common Stock, $0.001 par value (VYGR) has 115 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 28.9M shares
of 55.5M outstanding shares and own 52.11% of the company stock.
Largest 10 shareholders include TRV GP III, LLC (6.39M shares), BB BIOTECH AG (2.82M shares), BlackRock Inc. (1.86M shares), ARMISTICE CAPITAL, LLC (1.72M shares), GREAT POINT PARTNERS LLC (1.4M shares), FMR LLC (1.38M shares), STATE STREET CORP (1.3M shares), Vanguard Group Inc (1.2M shares), Casdin Capital, LLC (1.14M shares), and HIGHLINE CAPITAL MANAGEMENT, L.P. (1M shares).
This table shows the top 115 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.